Treatment of psoriasis with bromocriptin
โ Scribed by G. Weber; M. Neidhardt; H. Frey; K. Galle; A. Geiger
- Publisher
- Springer-Verlag
- Year
- 1981
- Tongue
- English
- Weight
- 165 KB
- Volume
- 271
- Category
- Article
- ISSN
- 0340-3696
No coin nor oath required. For personal study only.
โฆ Synopsis
Sixty patients suffering from psoriasis of all clinical forms have been treated with an increased dosage of Bromocriptin. The age of the patients ranged from 20 to 72 years. Patients with contraindications for Bromocriptin were excluded from the test. In 80% a remission or reduction of psoriasis lesions was noticed. Side effects in the form of nausea, dizziness and vomiting occurred in 15%, but decreased in the course of Bromocriptin therapy.
๐ SIMILAR VOLUMES
In 22 of 26 patients suffering from psoriasis the drip infusion therapy with Somatostatin, an inhibitor of the human growth hormone (HGH), leads to complete or partial remission of skin lesions. Fast reduction of joint pains in arthropathic psoriasis could be observed in four of four patients. The r
We studied the efficacy and tolerability of a repeatable long-acting parenteral depot-bromocriptine preparation (Parlodel LAR) in 14 acromegalic patients, 10 of whom had received oral bromocriptine therapy previously, 2 of them showing intolerance to oral bromocriptine. Patients received i.m. inject